Cargando…
The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
OBJECTIVE: Daptomycin, a cyclic lipopeptide that exhibits rapid, concentration-dependent bactericidal activity in vitro against a broad spectrum of Gram-positive pathogens, has now, since 2003, been approved in more than 70 countries and regions to treat skin and soft-tissue infections (SSTIs). The...
Autores principales: | Wang, Shou Zhen, Hu, Jun Tao, Zhang, Chi, Zhou, Wei, Chen, Xian Feng, Jiang, Liang Yan, Tang, Zhan Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078778/ https://www.ncbi.nlm.nih.gov/pubmed/24961714 http://dx.doi.org/10.1136/bmjopen-2013-004744 |
Ejemplares similares
-
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
por: Shaw, E, et al.
Publicado: (2015) -
Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
por: Oe, Kenichi, et al.
Publicado: (2021) -
Daptomycin-Associated Diarrhea: A Case Report and Review of the Literature
por: Awadelkarim, Abdalaziz M, et al.
Publicado: (2022) -
Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study
por: Chavanet, Pascal, et al.
Publicado: (2023) -
Let’s Talk About Antibiotics: a randomised trial of two interventions to reduce antibiotic misuse
por: Goggin, Kathy, et al.
Publicado: (2022)